A detailed history of Invesco Ltd. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Invesco Ltd. holds 209,419 shares of TEVA stock, worth $3.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
209,419
Previous 210,124 0.34%
Holding current value
$3.47 Million
Previous $2.19 Million 34.7%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$10.67 - $14.43 $7,522 - $10,173
-705 Reduced 0.34%
209,419 $2.95 Million
Q4 2023

Feb 12, 2024

SELL
$8.12 - $10.63 $71,253 - $93,278
-8,775 Reduced 4.01%
210,124 $2.19 Million
Q3 2023

Nov 13, 2023

BUY
$7.48 - $10.7 $19,126 - $27,359
2,557 Added 1.18%
218,899 $2.23 Million
Q2 2023

Aug 11, 2023

SELL
$7.2 - $9.47 $362,520 - $476,814
-50,350 Reduced 18.88%
216,342 $1.63 Million
Q1 2023

May 12, 2023

SELL
$8.36 - $11.37 $953,817 - $1.3 Million
-114,093 Reduced 29.96%
266,692 $2.36 Million
Q4 2022

Feb 13, 2023

BUY
$7.95 - $9.48 $21,011 - $25,055
2,643 Added 0.7%
380,785 $3.47 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $97,624 - $170,060
14,231 Added 3.91%
378,142 $3.05 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $111,556 - $157,206
15,116 Added 4.33%
363,911 $2.74 Million
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $30,031 - $38,470
4,097 Added 1.19%
348,795 $3.27 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $3.05 Million - $3.93 Million
-385,785 Reduced 52.81%
344,698 $2.76 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $1.98 Million - $2.4 Million
-235,841 Reduced 24.41%
730,483 $7.12 Million
Q2 2021

Aug 17, 2021

BUY
$9.9 - $11.56 $978,426 - $1.14 Million
98,831 Added 11.39%
966,324 $9.57 Million
Q1 2021

May 17, 2021

SELL
$10.34 - $12.81 $7 Million - $8.67 Million
-676,632 Reduced 43.82%
867,493 $10 Million
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $1.74 Million - $2.23 Million
202,388 Added 15.08%
1,544,125 $14.9 Million
Q3 2020

Nov 16, 2020

SELL
$8.57 - $12.69 $4.14 Million - $6.13 Million
-482,973 Reduced 26.47%
1,341,737 $12.1 Million
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $1.71 Million - $2.76 Million
-210,206 Reduced 10.33%
1,824,710 $22.5 Million
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $10.7 Million - $21.4 Million
1,594,441 Added 361.98%
2,034,916 $18.3 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $1.78 Million - $2.92 Million
271,981 Added 161.42%
440,475 $4.32 Million
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $307,494 - $479,212
49,918 Added 42.1%
168,494 $1.16 Million
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $516,310 - $999,556
63,585 Added 115.63%
118,576 $1.09 Million
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $229,493 - $294,747
14,730 Added 36.59%
54,991 $862,000
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $587,407 - $959,822
40,261 New
40,261 $621,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.